Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sangamo Therapeutics Announces Participation at the Jefferies Virtual Healthcare Conference

BusinessWire_EN 
0 0 29.05.20
Sangamo Therapeutics Announces Participation at the Jefferies Virtual Healthcare Conference
 

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2 at 4:00 p.m. ET.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200529005093/en/

Sangamo Therapeutics Inc. Stock

€0.48
7.500%
Sangamo Therapeutics Inc. dominated the market today, gaining €0.035 (7.500%).
With 11 Buy predictions and 12 Sell predictions the community is currently undecided on Sangamo Therapeutics Inc..
However, we have a potential of 316.49% for Sangamo Therapeutics Inc. as the target price of 2 € is above the current price of 0.48 €.
Show more
Like: 0
Share
BusinessWire_EN 
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments

Not a member yet? Sign up for free!